drugset / Trial / NCT00382837
Study of Epratuzumab in Systemic Lupus Erythematosus
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Epratuzumab is an investigational antibody designed to help treat SLE. The purpose is to evaluate safety and long term efficacy in concert with standard SLE treatments
Timeline
- Start
- 2007-01
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epratuzumab | Monoclonal antibody | — | — |